Biotech Sector Advances in Pancreatic Cancer Research
USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END
Why Aclaris Therapeutics Stock Soared Nearly 6% on Thursday
A bull on the company became more positive on its prospects.
2 Low-Priced Stocks That Could Make You Richer
These two low-priced healthcare stocks could skyrocket within the next 12 months.
Why Aclaris Therapeutics Topped the Market on Tuesday
Investors were cheered by the latest laboratory news from the company.
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
Aclaris (ACRS) delivered earnings and revenue surprises of 4.55% and 36.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?